NSUN2 and colorectal carcinoma: To this end, after NSUN2 expression levels were measured (Figure 6G), we implanted fresh primary tumour samples resected from CRC patients into immunocompromised mice and then intraperitoneally injected PBS or verteporfin, a disruptor of YAP/TAZ‐TEAD‐mediated transcription (Figure 6H).